Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CRIS

Curis (CRIS)

Curis Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CRIS
일자시간출처헤드라인심볼기업
2024/05/1021:00PR Newswire (US)Curis to Present Updated Data from the TakeAim Leukemia StudyNASDAQ:CRISCuris Inc
2024/05/0721:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
2024/05/0721:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/05/0721:00PR Newswire (US)Curis Provides First Quarter 2024 Business UpdateNASDAQ:CRISCuris Inc
2024/04/3021:00PR Newswire (US)Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024NASDAQ:CRISCuris Inc
2024/04/0520:30PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2024/04/0420:30PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in AprilNASDAQ:CRISCuris Inc
2024/02/1306:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRISCuris Inc
2024/02/0906:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRISCuris Inc
2024/02/0906:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRISCuris Inc
2024/02/0906:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRISCuris Inc
2024/02/0822:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/02/0822:00PR Newswire (US)Curis Provides Fourth Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
2024/02/0122:00PR Newswire (US)Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024NASDAQ:CRISCuris Inc
2024/01/1122:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2024/01/0522:00PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2023/12/2206:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CRISCuris Inc
2023/12/1222:00PR Newswire (US)Curis Announces Initial Combination Study Data from its TakeAim Lymphoma StudyNASDAQ:CRISCuris Inc
2023/12/1122:00PR Newswire (US)Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH ConferenceNASDAQ:CRISCuris Inc
2023/12/0622:00PR Newswire (US)Curis Announces Three Presentations at ASHNASDAQ:CRISCuris Inc
2023/12/0522:00PR Newswire (US)Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in MelanomaNASDAQ:CRISCuris Inc
2023/11/0221:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
2023/11/0221:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2023/11/0221:00PR Newswire (US)Curis Provides Third Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
2023/10/2621:30PR Newswire (US)Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023NASDAQ:CRISCuris Inc
2023/10/0621:56PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
2023/09/2905:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRISCuris Inc
2023/09/2821:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
2023/09/1221:00PR Newswire (US)Curis Announces Date for the 2nd Symposium on IRAK4 in CancerNASDAQ:CRISCuris Inc
2023/09/0621:13PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in SeptemberNASDAQ:CRISCuris Inc
 검색 관련기사 보기:NASDAQ:CRIS